
Levohypropizine
Price | Get Latest Price | |
Package | 1kg | 25kg |
Min. Order: | 1kg |
Supply Ability: | 900kg |
Update Time: | 2025-05-23 |
Product Details
Product Name: Levohypropizine | CAS No.: 54143-57-6 |
Min. Order: 1kg | Purity: 0.99 |
Supply Ability: 900kg | Release date: 2025/05/23 |
? ?Metoclopramide Monohydrochloride Monohydrate (CAS 54143-57-6) | USP/EP-Certified Gastroprokinetic & Antiemetic Agent? ?
?? ?Product Overview?
?Metoclopramide Monohydrochloride Monohydrate? (CAS 54143-57-6) is a high-purity ?dopamine D2 receptor antagonist? and ?prokinetic drug? with the molecular formula ?C??H??Cl?N?O?? and a molecular weight of ?354.27?. This white crystalline powder (purity ≥99%) is widely utilized to enhance gastrointestinal motility, prevent nausea/vomiting, and treat gastroparesis. It acts by accelerating gastric emptying and increasing lower esophageal sphincter pressure, achieving clinical effects within ?15–30 minutes? of administration?12.
?Key Functions?:
Stimulates upper GI motility for conditions like gastroparesis.
Reduces chemotherapy-induced and postoperative vomiting.
Serves as a reference standard in pharmaceutical quality control.
?Target Industries?: Pharmaceutical manufacturing, hospitals, and clinical research.
? ?Key Advantages?
≥99% HPLC/EP-certified purity | Oral, IV, or IM administration | Stable under controlled humidity |
Rapid onset (15–30 min) | Compatible with pediatric/adult dosing | Long shelf life (24 months) |
?? ?Applications?
?Gastrointestinal Disorders?: Treatment of diabetic gastroparesis, reflux esophagitis, and functional dyspepsia?.
?Oncology Support?: Management of chemotherapy-induced nausea and vomiting.
?Postoperative Care?: Prevention of delayed gastric emptying after surgery.
?? ?Quality Assurance?
?Certifications?: Complies with ?USP/EP? pharmacopeial standards and ?ISO 9001?
?Testing?: Validated via HPLC, NMR, and FTIR spectroscopy.
?Packaging?: Available in ?25kg? bulk drums or custom R&D batches (1g–10kg).
?? ?Market Insights?
The global gastrointestinal drugs market is projected to grow at ?4.9% CAGR (2025–2030)?, driven by rising demand for antiemetics and prokinetics in chronic disease management. Metoclopramide remains a cost-effective first-line therapy, with ?Asia-Pacific? leading production due to expanding generic drug manufacturing?2.
Company Profile Introduction
You may like
Recommended supplier
Product name | Price | Suppliers | Update time | |
---|---|---|---|---|
$10.00/1kg |
VIP1Y
|
Guangdong Junhua Chemical Co., Ltd
|
2025-02-28 | |
$10.00/1KG |
VIP7Y
|
Hebei Chuanghai Biotechnology Co., Ltd
|
2024-11-25 | |
$32.00/50mg |
VIP5Y
|
TargetMol Chemicals Inc.
|
2024-11-17 | |
$90.00/1kg |
VIP2Y
|
Guangzhou Tengyue Chemical Co., Ltd.
|
2023-12-20 | |
$0.00/25KG |
VIP5Y
|
Hebei Mujin Biotechnology Co.,Ltd
|
2023-08-28 | |
$10.00/1Kg/Bag |
Hebei Zhanyao Biotechnology Co. Ltd
|
2021-11-12 | ||
$9.00/1KG |
Shijiazhuang tongyang Import and Export Co., LTD
|
2021-08-13 | ||
$15.00/1KG |
Zhuozhou Wenxi import and Export Co., Ltd
|
2021-08-11 | ||
$0.00/1Kg/Bag |
VIP5Y
|
WUHAN FORTUNA CHEMICAL CO., LTD
|
2021-06-04 | |
$0.00/25Kg/Drum |
HubeiwidelychemicaltechnologyCo.,Ltd
|
2019-10-10 |
+86-+undefined-+86 13343427080
sales@biocarchem.com